{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:49:55Z","timestamp":1790999395351,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ab.2023.115156","type":"journal-article","created":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T09:20:41Z","timestamp":1681636841000},"page":"115156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype"],"prefix":"10.1016","volume":"672","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0332-1507","authenticated-orcid":false,"given":"Paige E.","family":"Lawler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia R.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J.","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Coulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7729-1702","authenticated-orcid":false,"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ab.2023.115156_bib1","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ab.2023.115156_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Roles of apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.ab.2023.115156_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ab.2023.115156_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","article-title":"Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins: thematic review series: ApoE and lipid homeostasis in Alzheimer's disease","volume":"58","author":"Huynh","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ab.2023.115156_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ab.2023.115156_bib6","doi-asserted-by":"crossref","unstructured":"C.-C. Liu, T. Kanekiyo, H. Xu, and G. Bu, \u201cApolipoprotein E and Alzheimer Disease: Risk, Mechanisms, and Therapy\u201d, doi: 10.1038\/nrneurol.2012.263.","DOI":"10.1038\/nrneurol.2012.263"},{"issue":"8","key":"10.1016\/j.ab.2023.115156_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.ab.2023.115156_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI115288","article-title":"Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation","volume":"88","author":"Linton","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ab.2023.115156_bib9","doi-asserted-by":"crossref","unstructured":"D. Chernick, S. Ortiz-Valle, A. Jeong, W. Qu, and L. Li, \u201cPeripheral versus Central Nervous System APOE in Alzheimer's Disease: Interplay across the Blood-Brain Barrier\u201d, doi: 10.1016\/j.neulet.2019.134306.","DOI":"10.1016\/j.neulet.2019.134306"},{"issue":"1","key":"10.1016\/j.ab.2023.115156_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"19","key":"10.1016\/j.ab.2023.115156_bib11","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ab.2023.115156_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","article-title":"Specific regional transcription of apolipoprotein E in human brain neurons","volume":"154","author":"Pu-Ting","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.ab.2023.115156_bib13","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1074\/jbc.M309475200","article-title":"Astroglial regulation of apolipoprotein E expression in neuronal cells: implications for ALZHEIMER\u2019S disease","volume":"279","author":"Harris","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2023.115156_bib14","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.ab.2023.115156_bib15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","article-title":"Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction","volume":"34","author":"Aoki","year":"2003","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ab.2023.115156_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.ab.2023.115156_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fnins.2021.688090","article-title":"Blood\u2013brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia","volume":"15","author":"Hussain","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ab.2023.115156_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","article-title":"Cell-specific production, secretion, and function of apolipoprotein E","volume":"96","author":"Kockx","year":"2018","journal-title":"J. Mol. Med."},{"issue":"9","key":"10.1016\/j.ab.2023.115156_bib19","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/S0021-9258(18)91039-2","article-title":"Synthesis, intracellular processing, and signal peptide of human apolipoprotein E","volume":"259","author":"Zannis","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ab.2023.115156_bib20","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ana.24454","article-title":"Age and amyloid effects on human CNS amyloid-beta kinetics HHS public access author manuscript","volume":"78","author":"Patterson","year":"2015","journal-title":"Ann. Neurol."},{"issue":"53","key":"10.1016\/j.ab.2023.115156_bib21","doi-asserted-by":"crossref","first-page":"27204","DOI":"10.1074\/jbc.M116.721779","article-title":"Human central nervous system (CNS) ApoE isoforms are increased by age, differentially altered by amyloidosis, and relative amounts reversed in the CNS compared with plasma","volume":"291","author":"Baker-Nigh","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2023.115156_bib22","doi-asserted-by":"crossref","unstructured":"Y. Mechref, \u201cUse of CID\/ETD Mass Spectrometry to Analyze Glycopeptides\u201d, doi: 10.1002\/0471140864.ps1211s68.","DOI":"10.1002\/0471140864.ps1211s68"},{"key":"10.1016\/j.ab.2023.115156_bib23","first-page":"104","article-title":"Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism","volume":"42","author":"Boerwinkle","year":"1988","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ab.2023.115156_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0021-9150(99)00501-8","article-title":"Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project","volume":"152","author":"Schiele","year":"2000","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ab.2023.115156_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-4886(03)00088-8","article-title":"APOE \u03b53\/\u03b54 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis","volume":"183","author":"Fukumoto","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ab.2023.115156_bib26","series-title":"Neurobiology of Disease Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels","author":"Riddell","year":"2008"},{"issue":"89","key":"10.1016\/j.ab.2023.115156_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ab.2023.115156_bib28","doi-asserted-by":"crossref","unstructured":"C. Cruchaga et al., \u201cCerebrospinal Fluid APOE Levels: an Endophenotype for Genetic Studies for Alzheimer's Disease\u201d, doi: 10.1093\/hmg\/dds296.","DOI":"10.1093\/hmg\/dds296"},{"key":"10.1016\/j.ab.2023.115156_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","article-title":"Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls","volume":"3","author":"Mart\u00ednez-Morillo","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ab.2023.115156_bib30","series-title":"Molecular Neurodegeneration Apolipoprotein E Levels in Cerebrospinal Fluid and the Effects of ABCA1 Polymorphisms","author":"Wahrle","year":"2007"},{"issue":"15","key":"10.1016\/j.ab.2023.115156_bib31","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1016\/S0021-9258(18)81907-X","article-title":"Glycosylation of human apolipoprotein E","volume":"264","author":"Wernette-Hammond","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ab.2023.115156_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/glycob\/cwz084","article-title":"O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain","volume":"30","author":"Flowers","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.ab.2023.115156_bib33","series-title":"LC\u2212MS\/MS Characterization of O-Glycosylation Sites and Glycan Structures of Human Cerebrospinal Fluid Glycoproteins","author":"Halim","year":"2012"},{"key":"10.1016\/j.ab.2023.115156_bib34","series-title":"Glycosylation and Sialylation of Macrophage-Derived Human Apolipoprotein E Analyzed by SDS-PAGE and Mass Spectrometry EVIDENCE for A NOVEL SITE of GLYCOSYLATION on SER 290 * \u25a1 S","author":"Lee","year":"2010"},{"issue":"11","key":"10.1016\/j.ab.2023.115156_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nmeth.1731","article-title":"Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines","volume":"8","author":"Steentoft","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ab.2023.115156_bib36","series-title":"Site-Specific Glycoprofiles of HDL-Associated ApoE Are Correlated with HDL Functional Capacity and Unaffected by Short-Term Diet","author":"Zhu","year":"2019"},{"key":"10.1016\/j.ab.2023.115156_bib37","doi-asserted-by":"crossref","unstructured":"P. Shah, S. Yang, S. Sun, P. Aiyetan, K. J. Yarema, and H. Zhang, \u201cMass Spectrometric Analysis of Sialylated Glycans Using Solid Phase Labeling of Sialc Acids\u201d, doi: 10.1021\/ac3033867.","DOI":"10.1021\/ac3033867"},{"key":"10.1016\/j.ab.2023.115156_bib38","series-title":"STRUCTURE ELUCIDATION OF NATIVE N-AND O-LINKED GLYCANS BY TANDEM MASS SPECTROMETRY","author":"An","year":"2010"},{"issue":"11","key":"10.1016\/j.ab.2023.115156_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.1392","article-title":"Enrichment of glycopeptides for glycan structure and attachment site identification","volume":"6","author":"Nilsson","year":"2009","journal-title":"Nature methods"},{"key":"10.1016\/j.ab.2023.115156_bib40","series-title":"Comparison of Glycopeptide Fragmentation by Collision Induced Dissociation and Ultraviolet Photodissociation","author":"Ko","year":"2014"},{"key":"10.1016\/j.ab.2023.115156_bib41","series-title":"LC\u2212MS\/MS of Glycopeptides","article-title":"Assignment of Saccharide Identities through Analysis of Oxonium Ion Fragmentation Profiles","author":"Halim","year":"2014"},{"issue":"9","key":"10.1016\/j.ab.2023.115156_bib42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0026-0495(99)90136-1","article-title":"Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver","volume":"48","author":"Marmillot","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.ab.2023.115156_bib43","author":"Huang","year":"2014","journal-title":"Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle"},{"key":"10.1016\/j.ab.2023.115156_bib44","unstructured":"P. Marmillot, M. N. Rao, Q.-H. Liu, and M. R. Lakshman, \u201cDesialylation of Human Apolipoprotein E Decreases its Binding to Human High-Density Lipoprotein and its Ability to Deliver Esterified Cholesterol to the Liver\u201d."},{"issue":"1","key":"10.1016\/j.ab.2023.115156_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0197-4580(94)90149-X","article-title":"A decrease in serum sialyltransferase levels in Alzheimer's disease","volume":"15","author":"Maguire","year":"1994","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.ab.2023.115156_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/biof.37","article-title":"Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E","volume":"35","author":"Fan","year":"2009","journal-title":"Biofactors"},{"issue":"8","key":"10.1016\/j.ab.2023.115156_bib47","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function","volume":"25","author":"Liu","year":"2022","journal-title":"Nature Neuroscience"},{"issue":"8","key":"10.1016\/j.ab.2023.115156_bib48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau-PET and amyloid-PET HHS Public Access","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269723001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269723001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:39:14Z","timestamp":1757713154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269723001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"alternative-id":["S0003269723001215"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2023.115156","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2023.115156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115156"}}